About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [4,760 citations: 1,201–1,300 of 3,805 articles]

Articles published in PPAR Research have been cited 4,760 times. The following is a list of the 3,805 articles that have cited the articles published in PPAR Research.

  • K. Sandy Pang, and Edwin C. Y. Chow, “Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption,” Current Drug Metabolism, vol. 14, no. 1, pp. 57–79, 2013. View at Publisher · View at Google Scholar
  • Osama H. Elshenawy, Ayman O. S. El-Kadi, and Anwar Anwar-Mohamed, “20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases,” Current Drug Metabolism, vol. 14, no. 6, pp. 706–719, 2013. View at Publisher · View at Google Scholar
  • Patrick G. Sullivan, and Heather M. Yonutas, “Targeting PPAR Isoforms Following CNS Injury,” Current Drug Targets, vol. 14, no. 7, pp. 733–742, 2013. View at Publisher · View at Google Scholar
  • Anna R. Carta, “PPAR-gamma: Therapeutic Prospects in Parkinson's Disease,” Current Drug Targets, vol. 14, no. 7, pp. 743–751, 2013. View at Publisher · View at Google Scholar
  • Sophie Gautier, Bart Staels, Dominique Deplanque, Patrick Duriez, Michele Bastide, Regis Bordet, Thavarak Ouk, Didier Leys, and Camille Potey, “PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke,” Current Drug Targets, vol. 14, no. 7, pp. 752–767, 2013. View at Publisher · View at Google Scholar
  • M. Scotece, J. J. Gomez-Reino, V. Lopez, F. Lago, J. Pino, and J. Conde, “Leptin in Joint and Bone Diseases: New Insights,” Current Medicinal Chemistry, vol. 20, no. 27, pp. 3416–3425, 2013. View at Publisher · View at Google Scholar
  • G. Sambataro, P. Piccinni, C. Spina, F. M. Sambataro, L. Navarini, and A. Dobrina, “Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment,” Current Medicinal Chemistry, vol. 20, no. 27, pp. 3370–3396, 2013. View at Publisher · View at Google Scholar
  • V. Gasperi, E. Dainese, S. Oddi, A. Sabatucci, and M. Maccarrone, “GPR55 and its interaction with membrane lipids: Comparison with other endocannabinoid-binding receptors,” Current Medicinal Chemistry, vol. 20, no. 1, pp. 64–78, 2013. View at Publisher · View at Google Scholar
  • U. R. Markert, A. Pestka, J. S. Fitzgerald, and B. Toth, “Nuclear Hormone Receptors and Female Reproduction,” Current Molecular Medicine, vol. 13, no. 7, pp. 1066–1078, 2013. View at Publisher · View at Google Scholar
  • S. Baldelli, M. R. Ciriolo, B. Pagliei, and K. Aquilano, “Extranuclear Localization of SIRT1 and PGC-1 alpha: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction,” Current Molecular Medicine, vol. 13, no. 1, pp. 140–154, 2013. View at Publisher · View at Google Scholar
  • Carole A. Conn, Roger A. Vaughan, and William S. Garver, “Nutritional Genetics and Energy Metabolism in Human Obesity,” Current Nutrition Reports, 2013. View at Publisher · View at Google Scholar
  • Laureane N. Masi, Alice C. Rodrigues, and Rui Curi, “Fatty acids regulation of inflammatory and metabolic genes,” Current Opinion in Clinical Nutrition and Metabolic Care, pp. 1, 2013. View at Publisher · View at Google Scholar
  • Emily J. Gallagher, and Derek LeRoith, “Diabetes, antihyperglycemic medications and cancer risk,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 20, no. 5, pp. 485–494, 2013. View at Publisher · View at Google Scholar
  • William T Gerthoffer, Julian Solway, and Blanca Camoretti-Mercado, “Emerging targets for novel therapy of asthma,” Current Opinion in Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Jenny Cook, and Thorsten Hagemann, “Tumour-associated macrophages and cancer,” Current Opinion in Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Malgorzata Pierzchalska, Krzysztof Reiss, and Maja Grabacka, “Peroxisome Proliferator Activated Receptor alpha Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism,” Current Pharmaceutical Biotechnology, vol. 14, no. 3, pp. 342–356, 2013. View at Publisher · View at Google Scholar
  • Leandro Martin Velez, Alicia Beatriz Motta, and Giselle Adriana Abruzzese, “The Biology of the Peroxisome Proliferator-activated Receptor System in the Female Reproductive Tract,” Current Pharmaceutical Design, vol. 19, no. 25, pp. 4641–4646, 2013. View at Publisher · View at Google Scholar
  • Maria Cristina Manara, Antonino Belfiore, Stefano Ferrari, Cecilia Garofalo, and Katia Scotlandi, “Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis,” Current Pharmaceutical Design, vol. 19, no. 30, pp. 5344–5361, 2013. View at Publisher · View at Google Scholar
  • Michael S. Kostapanos, and Moses S. Elisaf, “Pioglitazone and Cancer: Angel or Demon?,” Current Pharmaceutical Design, vol. 19, no. 27, pp. 4913–4929, 2013. View at Publisher · View at Google Scholar
  • Milagros Rocha, Rosa Falcon, Jose R. Herance, Antonio Hernandez-Mijares, Carlos Morillas, Celia Banuls, Susana Rovira-Llopis, Lorena Bellod, and Raquel Castello, “Mitochondrial Dysfunction and Oxidative Stress in Insulin Resistance,” Current Pharmaceutical Design, vol. 19, no. 32, pp. 5730–5741, 2013. View at Publisher · View at Google Scholar
  • Wyi Sian Lim, Di Lin Ng, Sue Bee Kor, Hong Kin Wong, Tengku Sifzizul Tengku-Muhammad, Quok Cheong Choo, and Choy Hoong Chew, “Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway,” Cytokine, vol. 61, no. 1, pp. 266–274, 2013. View at Publisher · View at Google Scholar
  • U. Jeschke, “Plazentaforschung,” Der Gynäkologe, vol. 46, no. 11, pp. 798–802, 2013. View at Publisher · View at Google Scholar
  • Wen-Yan Li, Yang-Liu Song, Cheng-Juan Xiong, Pei-Qi Lu, Li-Xiang Xue, Chun-Xia Yao, Wei-Ping Wang, Shu-Feng Zhang, Shan-Feng Zhang, Qing-Xia Wei, Yan-Yan Zhang, Ji-Min Zhao, and Ming-Xi Zang, “Insulin induces proliferation and cardiac differentiation of P19CL6 cells in a dose-dependent manner,” Development, Growth & Differentiation, vol. 55, no. 7, pp. 676–686, 2013. View at Publisher · View at Google Scholar
  • Sanshiro Tateya, Alexander W. Clowes, Alan Chait, Francis Kim, Norma Rizzo-De Leon, Priya Handa, Andrew M. Cheng, Vicki Morgan-Stevenson, Kayoko Ogimoto, Jenny E. Kanter, Karin E. Bornfeldt, and Guenter Daum, “VASP increases hepatic fatty acid oxidation by activating AMPK in mice,” Diabetes, vol. 62, no. 6, pp. 1913–1922, 2013. View at Publisher · View at Google Scholar
  • Li Wang, Ruifeng Teng, Lijun Di, Heather Rogers, Hong Wu, Jeffrey B. Kopp, and Constance Tom Noguchi, “PPAR alpha and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders,” Diabetes, vol. 62, no. 12, pp. 4122–4131, 2013. View at Publisher · View at Google Scholar
  • Hannah Seok, and Bong Soo Cha, “Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes,” Diabetes & Metabolism Journal, vol. 37, no. 5, pp. 326, 2013. View at Publisher · View at Google Scholar
  • Cesar Corzo, and Patrick R. Griffin, “Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity,” Diabetes & Metabolism Journal, vol. 37, no. 6, pp. 395, 2013. View at Publisher · View at Google Scholar
  • Qibin Qi, James B. Meigs, Kathryn M. Rexrode, Frank B. Hu, and Lu Qi, “Diabetes Genetic Predisposition Score and Cardiovascular Complications Among Patients With Type 2 Diabetes,” Diabetes Care, vol. 36, no. 3, pp. 737–739, 2013. View at Publisher · View at Google Scholar
  • Philip Home, “Insulin Therapy and Cancer,” Diabetes Care, vol. 36, pp. S240–S244, 2013. View at Publisher · View at Google Scholar
  • George Grunberger, “Will PPAR-γ agonist therapy still have a role in diabetes management in 2013?,” Diabetes Management, vol. 3, no. 1, pp. 41–51, 2013. View at Publisher · View at Google Scholar
  • A. Consoli, and G. Formoso, “Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?,” Diabetes, Obesity and Metabolism, 2013. View at Publisher · View at Google Scholar
  • S. K. Garg, H. Maurer, K. Reed, and R. Selagamsetty, “Diabetes and cancer: two diseases with obesity as a common risk factor,” Diabetes, Obesity and Metabolism, 2013. View at Publisher · View at Google Scholar
  • L. O'Keefe, A. C. Simcocks, D. H. Hryciw, M. L. Mathai, and A. J. McAinch, “The cannabinoid receptor 1 and its role in influencing peripheral metabolism,” Diabetes, Obesity and Metabolism, 2013. View at Publisher · View at Google Scholar
  • P. Matafome, D. Santos-Silva, C. M. Sena, and R. Seiça, “Common mechanisms of dysfunctional adipose tissue and obesity-related cancers,” Diabetes/Metabolism Research and Reviews, vol. 29, no. 4, pp. 285–295, 2013. View at Publisher · View at Google Scholar
  • W. Zheng, X. Feng, L. Qiu, Z. Pan, R. Wang, S. Lin, D. Hou, L. Jin, and Y. Li, “Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes,” Diabetologia, vol. 56, no. 2, pp. 401–411, 2013. View at Publisher · View at Google Scholar
  • M. P. Czech, M. Tencerova, D. J. Pedersen, and M. Aouadi, “Insulin signalling mechanisms for triacylglycerol storage,” Diabetologia, vol. 56, no. 5, pp. 949–964, 2013. View at Publisher · View at Google Scholar
  • Ping Xu, Xiao-Li Lou, Cheng Chen, and Zhi-Wen Yang, “Effects of Peroxisome Proliferator-Activated Receptor-γ Activation on Apoptosis in Rats with Acute Pancreatitis,” Digestive Diseases and Sciences, 2013. View at Publisher · View at Google Scholar
  • Selda Kabadere, Gokhan Kus, Ruhi Uyar, and Pinar Oztopcu-Vatan, “Licofelone abolishes survival of carcinogenic fibroblasts by inducing apoptosis,” Drug and Chemical Toxicology, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Barna Peitl, Laszlo Drimba, Peter Hari, Andras Malnasi-Csizmadia, Jozsef Nemeth, Zoltan Szilvassy, Diana Kovacs, Zoltan Simon, Csaba Hegedus, and Reka Sari, “Identification of PPAR gamma ligands with One-dimensional Drug Profile Matching,” Drug Design Development And Therapy, vol. 7, pp. 917–928, 2013. View at Publisher · View at Google Scholar
  • Morena Scotece, Javier Conde, Katriina Vuolteenaho, Anna Koskinen, Veronica López, Juan Gómez-Reino, Francisca Lago, Eeva Moilanen, and Oreste Gualillo, “Adipokines as drug targets in joint and bone disease,” Drug Discovery Today, 2013. View at Publisher · View at Google Scholar
  • I-Chun Tsai, and Nicholas Katsanis, “Renal cystic disease: from mechanisms to drug development,” Drug Discovery Today: Disease Mechanisms, 2013. View at Publisher · View at Google Scholar
  • Eric A. Evangelista, Ruediger Kaspera, Nahush A. Mokadam, J. P. Jones, and Rheem A. Totah, “Activity, Inhibition, and Induction of Cytochrome P450 2J2 in Adult Human Primary Cardiomyocytes,” Drug Metabolism and Disposition, vol. 41, no. 12, pp. 2087–2094, 2013. View at Publisher · View at Google Scholar
  • Melissa Runge-Morris, Thomas A. Kocarek, and Charles N. Falany, “Regulation of the cytosolic sulfotransferases by nuclear receptors,” Drug Metabolism Reviews, vol. 45, no. 1, pp. 15–33, 2013. View at Publisher · View at Google Scholar
  • German Ramirez, Anthony D. Morrison, and Polly A. Bittle, “Clinical Practice Considerations and Review of the Literature for the Use of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease,” Endocrine Practice, vol. 1, no. -1, pp. 1–33, 2013. View at Publisher · View at Google Scholar
  • Emily J. Gallagher, and Derek LeRoith, “Diabetes, Antihyperglycemic Medications and Cancer Risk: Smoke or Fire?,” Endocrine Practice, vol. 1, no. -1, pp. 1–28, 2013. View at Publisher · View at Google Scholar
  • Shi Nan Yin, Min Liu, Dan Qing Jing, Yi Ming Mu, Ju Ming Lu, and Chang Yu Pan, “Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells,” Endocrine Research, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • H. Herschel Conaway, and Petra Henning, “Vitamin A Metabolism, Action, and Role in Skeletal Homeostasis,” Endocrine Reviews, vol. 34, no. 6, pp. 766–797, 2013. View at Publisher · View at Google Scholar
  • Anindita Nandi, and Leonid Poretsky, “Diabetes and the Female Reproductive System,” Endocrinology and Metabolism Clinics of North America, 2013. View at Publisher · View at Google Scholar
  • Daniel Borg, Bert-Ove Lund, Nils-Gunnar Lindquist, and Helen Håkansson, “Cumulative health risk assessment of 17 perfluoroalkylated and polyfluoroalkylated substances (PFASs) in the Swedish population,” Environment International, vol. 59, pp. 112–123, 2013. View at Publisher · View at Google Scholar
  • John P. Vanden Heuvel, “Comment on “Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans” by Fletcher et al., Environment International 57-58 (2013) 2–10,” Environment International, 2013. View at Publisher · View at Google Scholar
  • Lianying Zhang, Xiao-Min Ren, and Liang-Hong Guo, “Structure-Based Investigation on the Interaction of Perfluorinated Compounds with Human Liver Fatty Acid Binding Protein,” Environmental Science & Technology, pp. 130920105151005, 2013. View at Publisher · View at Google Scholar
  • Gloria B. Post, Judith B. Louis, R. Lee Lippincott, and Nicholas A. Procopio, “Occurrence of Perfluorinated Compounds in Raw Water from New Jersey Public Drinking Water Systems,” Environmental Science & Technology, vol. 47, no. 23, pp. 13266–13275, 2013. View at Publisher · View at Google Scholar
  • Maryam Peymani, Ali Ghoochani, Kamran Ghaedi, Fereshteh Karamali, Khadijeh Karbalaie, Abbas Kiani-Esfahani, Farzaneh Rabiee, Mohammad Hossein Nasr-Esfahani, and Hossein Baharvand, “Dual effects of peroxisome proliferator-activated receptor γ on embryonic stem cell self-renewal in presence and absence of leukemia inhibitory factor,” European Journal of Cell Biology, vol. 92, no. 4-5, pp. 160–168, 2013. View at Publisher · View at Google Scholar
  • Michael S. Kostapanos, Matilda Florentin, and Moses S. Elisaf, “Fenofibrate and the kidney: an overview,” European Journal of Clinical Investigation, vol. 43, no. 5, pp. 522–531, 2013. View at Publisher · View at Google Scholar
  • Paula Boaventura, Dina Pereira, Ricardo Celestino, Adelia Mendes, Tadao Nakasawa, Jose Teixeira-Gomes, Manuel Sobrinho-Simoes, and Paula Soares, “Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment,” European Journal of Endocrinology, vol. 169, no. 5, pp. 673–679, 2013. View at Publisher · View at Google Scholar
  • Daya S. Srivastava, W. Haq, S. B. Katti, Saman Raza, Arvind K. Srivastava, and Swayam P. Srivastava, “Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents,” European Journal Of Medicinal Chemistry, vol. 63, pp. 611–620, 2013. View at Publisher · View at Google Scholar
  • Misael Ferreira, Laura Sartori Assunção, Fabíola Branco Filippin-Monteiro, Tânia Beatriz Creczynski-Pasa, and Marcus Mandolesi Sá, “Synthesis of 1,3-thiazine-2,4-diones with potential anticancer activity,” European Journal of Medicinal Chemistry, 2013. View at Publisher · View at Google Scholar
  • Hiroko Matsuda, Mayumi Sato, Mako Yakushiji, Manami Koshiguchi, Shizuka Hirai, and Yukari Egashira, “Regulation of rat hepatic α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase, a key enzyme in the tryptophan-NAD pathway, by dietary cholesterol and sterol regulatory element-binding protein-2,” European Journal of Nutrition, 2013. View at Publisher · View at Google Scholar
  • José Roberto Santin, Flávia D.T. Uchôa, Maria do Carmo A. Lima, Marcelo M. Rabello, Isabel Daufenback Machado, Marcelo Z. Hernandes, Angelica A. Amato, Flora Aparecida Milton, Paul Webb, Francisco de Assis Rocha Neves, Suely L. Galdino, Ivan Rocha Pitta, and Sandra H.P. Farsky, “Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor,” European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 689–697, 2013. View at Publisher · View at Google Scholar
  • Li Jing, Yu Zhang, Shengjie Fan, Ming Gu, Yu Guan, Xiong Lu, Cheng Huang, and Zhiqin Zhou, “Preventive and ameliorating effects of citrus d-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-Induced obesity,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hana Cernecka, Katarina Ochodnicka-Mackovicova, Dana Kucerova, Jana Kmecova, Viera Nemcekova, Gabriel Doka, Jan Kyselovic, Peter Krenek, Peter Ochodnicky, and Jan Klimas, “Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Lifang Zhang, Xiaoman Chu, Hong Wang, Hao Xie, Cen Guo, Lijuan Cao, Xueyan Zhou, Guangji Wang, and Haiping Hao, “Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver,” European Journal of Pharmacology, vol. 721, no. 1-3, pp. 277–285, 2013. View at Publisher · View at Google Scholar
  • Ke Hu, Yu Yang, Qiuyun Tu, Yingquan Luo, and Ruoting Ma, “Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Doaa I. Mohamed, Ahmed A.M. Elmelegy, Lubna F.A. El-Aziz, Hala S. Abdel kawy, Abeer A. Abd El-Samad, and Omnyah A. El-Kharashi, “Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Fernanda C. de Mesquita, Shanna Bitencourt, Eduardo Caberlon, Gabriela V. da Silva, Bruno S. Basso, Julia Schmid, Gabriela A. Ferreira, Fernanda dos Santos de Oliveira, and Jarbas R. de Oliveira, “Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Christopher P. Stanley, Amanda J. Wheal, Michael D. Randall, and Saoirse E. O'Sullivan, “Cannabinoids Alter Endothelial Function In The Zucker Rat Model Of Type 2 Diabetes,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hassan Malekinejad, Masoud Mehrabi, Mona Khoramjouy, and Ali Rezaie-Golmisheh, “Antifibrotic effect of Atorvastatin on Paraquat-induced pulmonary fibrosis: Role of PPAR γ receptors,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Jancy Stephen, Chris Delvecchio, Naomi Spitale, Amanda Giesler, Katherine Radford, Pat Bilan, P. Gerard Cox, John P. Capone, and Parameswaran Nair, “PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis,” European Respiratory Journal, vol. 41, no. 2, pp. 425–432, 2013. View at Publisher · View at Google Scholar
  • Ming Gu, Shengjie Fan, Gaigai Liu, Lu Guo, Xiaobo Ding, Yan Lu, Yu Zhang, Guang Ji, and Cheng Huang, “Extract of Wax Gourd Peel Prevents High-Fat Diet-Induced Hyperlipidemia in C57BL/6 Mice via the Inhibition of the PPAR Pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • Tushar P. Patel, Sanket Soni, Pankti Parikh, Jeetendra Gosai, Ragitha Chruvattil, and Sarita Gupta, “Swertiamarin: An Active Lead from Enicostemma littorale Regulates Hepatic and Adipose Tissue Gene Expression by Targeting PPAR-γ and Improves Insulin Sensitivity in Experimental NIDDM Rat Model,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • S. Vogl, A. G. Atanasov, M. Binder, M. Bulusu, M. Zehl, N. Fakhrudin, E. H. Heiss, P. Picker, C. Wawrosch, J. Saukel, G. Reznicek, E. Urban, V. Bochkov, V. M. Dirsch, and B. Kopp, “The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of Inflammation,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Woong Sun Jang, and Se Young Choung, “Antiobesity Effects of the Ethanol Extract of Laminaria japonica Areshoung in High-Fat-Diet-Induced Obese Rat,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–17, 2013. View at Publisher · View at Google Scholar
  • Di Chen, Fangbo Zhang, Shihuan Tang, Yan Chen, Peng Lu, Shaoxin Wen, Hongchun Zhang, Xi Liu, Enxiang Chao, and Hongjun Yang, “A Network-Based Systematic Study for the Mechanism of the Treatment of Zhengs Related to Cough Variant Asthma,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  • Nur Akmal Ishak, Maznah Ismail, Muhajir Hamid, Zalinah Ahmad, and Siti Aisyah Abd Ghafar, “Antidiabetic and Hypolipidemic Activities of Curculigo latifolia Fruit:Root Extract in High Fat Fed Diet and Low Dose STZ Induced Diabetic Rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Monica Viladomiu, Raquel Hontecillas, Pinyi Lu, and Josep Bassaganya-Riera, “Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituents,” Evidence-Based Complementary And Alternative Medicine, 2013. View at Publisher · View at Google Scholar
  • Jing-Ru Weng, Li-Yuan Bai, Chang-Fang Chiu, Jing-Lan Hu, Shih-Jiuan Chiu, and Chia-Yung Wu, “Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • T. Auguet, F. Sabench, A. Lucas, S. Pellitero, D. Del Castillo, C. Richart, X. Terra, Y. Quintero, S. Martínez, N. Manresa, J.A. Porras, C. Aguilar, J.M. Orellana-Gavaldà, and M. Hernández, “Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease,” Experimental and Clinical Endocrinology and Diabetes, vol. 121, no. 2, pp. 119–124, 2013. View at Publisher · View at Google Scholar
  • Jinru Wei, Quan Tang, Lijuan Liu, and Jianbin Bin, “Combination of peroxisome proliferator-activated receptor alpha/gamma agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion,” Experimental And Therapeutic Medicine, vol. 5, no. 3, pp. 783–788, 2013. View at Publisher · View at Google Scholar
  • Achim Salamon, Anika Jonitz, Stefanie Adam, Joachim Rychly, Brigitte Müller-Hilke, Rainer Bader, Katrin Lochner, and Kirsten Peters, “Articular Cartilage-Derived Cells Hold a Strong Osteogenic Differentiation Potential in Comparison to Mesenchymal Stem Cells In Vitro,” Experimental Cell Research, 2013. View at Publisher · View at Google Scholar
  • Martina C. Herwig, Chris Bergstrom, Jill R. Wells, Tobias Höller, and Hans E. Grossniklaus, “M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles,” Experimental Eye Research, vol. 107, pp. 52–58, 2013. View at Publisher · View at Google Scholar
  • Jun Tang, Yijin Pei, and Guangji Zhou, “When aging-onset diabetes is coming across with Alzheimer disease: Comparable pathogenesis and therapy,” Experimental Gerontology, vol. 48, no. 8, pp. 744–750, 2013. View at Publisher · View at Google Scholar
  • Sarah A. Woller, and Michelle A. Hook, “Opioid administration following spinal cord injury: Implications for pain and locomotor recovery,” Experimental Neurology, 2013. View at Publisher · View at Google Scholar
  • Juan Carlos Corona, Senio Campos de Souza, and Michael R. Duchen, “PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1,” Experimental Neurology, 2013. View at Publisher · View at Google Scholar
  • Siripong Palee, Punate Weerateerangkul, Kroekkiat Chinda, Siriporn C. Chattipakorn, and Nipon Chattipakorn, “Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemiareperfusion,” Experimental Physiology, vol. 98, no. 5, pp. 1028–1037, 2013. View at Publisher · View at Google Scholar
  • Swapan K Ghosh, and Roshni Roy Chowdhury, “Synthetic adjuvants for vaccine formulations: phytol derivatives,” Expert Opinion on Drug Delivery, vol. 10, no. 4, pp. 437–450, 2013. View at Publisher · View at Google Scholar
  • Katsutoshi Yoshizato, and Chise Tateno, “A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–17, 2013. View at Publisher · View at Google Scholar
  • Michele Bortolini, Matthew B Wright, Martin Bopst, and Bogdana Balas, “Examining the safety of PPAR agonists – current trends and future prospects,” Expert Opinion on Drug Safety, vol. 12, no. 1, pp. 65–79, 2013. View at Publisher · View at Google Scholar
  • Florian Lang, and Jakob Voelkl, “Therapeutic potential of serum and glucocorticoid inducible kinase inhibition,” Expert Opinion on Investigational Drugs, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  • Sana Khan, Saba Khan, Mohammed Imran, Krishna Kolappa Pillai, Mohd Akhtar, and Abul Kalam Najmi, “Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus – targeting thrombogenesis,” Expert Opinion on Therapeutic Targets, vol. 17, no. 6, pp. 627–639, 2013. View at Publisher · View at Google Scholar
  • Florian Lang, and Ekaterina Shumilina, “Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1,” Faseb Journal, vol. 27, no. 1, pp. 3–12, 2013. View at Publisher · View at Google Scholar
  • Tengis S. Pavlov, Daria V. Ilatovskaya, Vladislav Levchenko, Lijun Li, Carolyn M. Ecelbarger, and Alexander Staruschenko, “Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct,” Faseb Journal, vol. 27, no. 7, pp. 2723–2732, 2013. View at Publisher · View at Google Scholar
  • Pu Wang, Pei-Pei Guan, Chuang Guo, Fei Zhu, Konstantinos Konstantopoulos, and Zhan-You Wang, “Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases,” Faseb Journal, vol. 27, no. 12, pp. 4664–4677, 2013. View at Publisher · View at Google Scholar
  • María G. Zubiría, Juan P. Fariña, Griselda Moreno, Juan J. Gagliardino, Eduardo Spinedi, and Andrés Giovambattista, “Excess fructose intake-induced hypertrophic visceral adipose tissue results from unbalanced precursor cell adipogenic signals,” FEBS Journal, 2013. View at Publisher · View at Google Scholar
  • Stephen Hyter, and Arup K. Indra, “Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis,” FEBS Letters, vol. 587, no. 6, pp. 529–541, 2013. View at Publisher · View at Google Scholar
  • Avery L. McIntosh, Anca D. Petrescu, Heather A. Hostetler, Ann B. Kier, and Friedhelm Schroeder, “Liver-type Fatty Acid Binding Protein Interacts with Hepatocyte Nuclear Factor 4α,” FEBS Letters, 2013. View at Publisher · View at Google Scholar
  • Samuel Rommelaere, Virginie Millet, Thomas Gensollen, Christophe Bourges, Jerome Eeckhoute, Nathalie Hennuyer, Eric Bauge, Lionel Chasson, Ivana Cacciatore, Bart Staels, Giuseppina Pitari, and Philippe Naquet, “PPARalpha regulates the production of serum Vanin-1 by liver,” Febs Letters, vol. 587, no. 22, pp. 3742–3748, 2013. View at Publisher · View at Google Scholar
  • Nasrin Ziamajidi, Shahnaz Khaghani, Gholamreza Hassanzadeh, Safura Vardasbi, Shahram Ahmadian, Azin Nowrouzi, Seyed Mahmood Ghaffari, and Afshin Abdirad, “Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1,” Food and Chemical Toxicology, vol. 58, pp. 198–209, 2013. View at Publisher · View at Google Scholar
  • Xi Chen, Qizhi Qin, Wenjuan Zhang, Youjian Zhang, Hongyan Zhen, Chuanyao Liu, Yuqing Yang, Wei Xiong, and Jing Yuan, “Activation of the PI3K-AKT-mTOR signaling pathway promotes DEHP-induced Hep3B cell proliferation,” Food and Chemical Toxicology, 2013. View at Publisher · View at Google Scholar
  • Yueyue Zhang, Lingling Zhang, Jin Sun, Jian-Wen Qiu, Xiaoli Hu, Jingjie Hu, and Zhenmin Bao, “Proteomic analysis identifies proteins related to carotenoid accumulation in Yesso scallop (Patinopecten yessoensis),” Food Chemistry, 2013. View at Publisher · View at Google Scholar
  • Lorenza Putignani, Ornella Massa, and Anna Alisi, “Engineered Escherichia coli as new source of flavonoids and terpenoids,” Food Research International, 2013. View at Publisher · View at Google Scholar